236 related articles for article (PubMed ID: 19926611)
1. Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms.
Hrushesky WJ; Grutsch J; Wood P; Yang X; Oh EY; Ansell C; Kidder S; Ferrans C; Quiton DF; Reynolds J; Du-Quiton J; Levin R; Lis C; Braun D
Integr Cancer Ther; 2009 Dec; 8(4):387-97. PubMed ID: 19926611
[TBL] [Abstract][Full Text] [Related]
2. The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day.
Yang X; Wood PA; Ansell CM; Quiton DF; Oh EY; Du-Quiton J; Hrushesky WJ
Chronobiol Int; 2009 Oct; 26(7):1323-39. PubMed ID: 19916834
[TBL] [Abstract][Full Text] [Related]
3. Daily coordination of cancer growth and circadian clock gene expression.
You S; Wood PA; Xiong Y; Kobayashi M; Du-Quiton J; Hrushesky WJ
Breast Cancer Res Treat; 2005 May; 91(1):47-60. PubMed ID: 15868431
[TBL] [Abstract][Full Text] [Related]
4. Clock genes and cancer.
Wood PA; Yang X; Hrushesky WJ
Integr Cancer Ther; 2009 Dec; 8(4):303-8. PubMed ID: 20042409
[TBL] [Abstract][Full Text] [Related]
5. Circadian disruption, shift work and the risk of cancer: a summary of the evidence and studies in Seattle.
Davis S; Mirick DK
Cancer Causes Control; 2006 May; 17(4):539-45. PubMed ID: 16596308
[TBL] [Abstract][Full Text] [Related]
6. Lighting for the human circadian clock: recent research indicates that lighting has become a public health issue.
Pauley SM
Med Hypotheses; 2004; 63(4):588-96. PubMed ID: 15325001
[TBL] [Abstract][Full Text] [Related]
7. Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm.
Yang X; Wood PA; Oh EY; Du-Quiton J; Ansell CM; Hrushesky WJ
Breast Cancer Res Treat; 2009 Sep; 117(2):423-31. PubMed ID: 18651214
[TBL] [Abstract][Full Text] [Related]
8. Hormonal and pharmacological manipulation of the circadian clock: recent developments and future strategies.
Richardson G; Tate B
Sleep; 2000 May; 23 Suppl 3():S77-85. PubMed ID: 10809190
[TBL] [Abstract][Full Text] [Related]
9. Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics.
Lévi F; Filipski E; Iurisci I; Li XM; Innominato P
Cold Spring Harb Symp Quant Biol; 2007; 72():465-75. PubMed ID: 18419306
[TBL] [Abstract][Full Text] [Related]
10. Artificial lighting in the industrialized world: circadian disruption and breast cancer.
Stevens RG
Cancer Causes Control; 2006 May; 17(4):501-7. PubMed ID: 16596303
[TBL] [Abstract][Full Text] [Related]
11. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers.
Chen ST; Choo KB; Hou MF; Yeh KT; Kuo SJ; Chang JG
Carcinogenesis; 2005 Jul; 26(7):1241-6. PubMed ID: 15790588
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppression and circadian function.
Chen-Goodspeed M; Lee CC
J Biol Rhythms; 2007 Aug; 22(4):291-8. PubMed ID: 17660446
[TBL] [Abstract][Full Text] [Related]
13. The role of cell-specific circadian clocks in metabolism and disease.
Bray MS; Young ME
Obes Rev; 2009 Nov; 10 Suppl 2():6-13. PubMed ID: 19849797
[TBL] [Abstract][Full Text] [Related]
14. Novel insights from genetic and molecular characterization of the human clock.
Ptácek LJ; Jones CR; Fu YH
Cold Spring Harb Symp Quant Biol; 2007; 72():273-7. PubMed ID: 18419283
[TBL] [Abstract][Full Text] [Related]
15. Circadian effects in cancer-relevant psychoneuroendocrine and immune pathways.
Eismann EA; Lush E; Sephton SE
Psychoneuroendocrinology; 2010 Aug; 35(7):963-76. PubMed ID: 20097011
[TBL] [Abstract][Full Text] [Related]
16. [Circadian rhythm study from anticipatory behavior to drug treatment].
Shibata S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Oct; 25(5):251-8. PubMed ID: 16313103
[TBL] [Abstract][Full Text] [Related]
17. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.
Lévi F; Focan C; Karaboué A; de la Valette V; Focan-Henrard D; Baron B; Kreutz F; Giacchetti S
Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1015-35. PubMed ID: 17692427
[TBL] [Abstract][Full Text] [Related]
18. Electric light causes cancer? Surely you're joking, Mr. Stevens.
Stevens RG
Mutat Res; 2009; 682(1):1-6. PubMed ID: 19401186
[TBL] [Abstract][Full Text] [Related]
19. Melatonin, sleep disturbance and cancer risk.
Blask DE
Sleep Med Rev; 2009 Aug; 13(4):257-64. PubMed ID: 19095474
[TBL] [Abstract][Full Text] [Related]
20. Phenotype of Per1- and Per2-expressing neurons in the suprachiasmatic nucleus of a diurnal rodent (Arvicanthis ansorgei): comparison with a nocturnal species, the rat.
Dardente H; Klosen P; Caldelas I; Pévet P; Masson-Pévet M
Cell Tissue Res; 2002 Oct; 310(1):85-92. PubMed ID: 12242487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
